Cargando...
NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
BACKGROUND: With the advent of CRISPR-Cas9 genome editing tool in gene therapy, identification of aberrantly expressed genes is of great value across various cancer types. Since a large number of patients may benefit from molecular targeted gene therapy. The purpose of this study was to identify abe...
Gardado en:
| Publicado en: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7142249/ https://ncbi.nlm.nih.gov/pubmed/32300299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00387 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|